Information Provided By:
Fly News Breaks for April 1, 2015
SRPT
Apr 1, 2015 | 08:16 EDT
After Sarepta (SRPT) announced that its CEO had resigned and would be replaced on an interim basis by Chief Medical Officer Ed Kaye, SunTrust says it is "very pleased" by Kaye's promotion. Kaye has always been "a stabilizing force" at Sarepta, while his experience in developing orphan drugs has always been well-appreciated by the Street and he is "the ideal chaperon" for Sarepta's eteplirsen drug, the firm stated. However, SunTrust keeps a Neutral rating on the shares.
News For SRPT From the Last 2 Days
There are no results for your query SRPT